10x Genomics, Inc.·4

Nov 23, 5:02 PM ET

McAnear Justin J. 4

4 · 10x Genomics, Inc. · Filed Nov 23, 2022

Insider Transaction Report

Form 4
Period: 2022-11-22
McAnear Justin J.
Chief Financial Officer
Transactions
  • Sale

    Class A Common Stock

    2022-11-22$34.07/sh288$9,81176,764 total
  • Sale

    Class A Common Stock

    2022-11-22$34.07/sh686$23,36977,704 total
  • Sale

    Class A Common Stock

    2022-11-22$34.07/sh652$22,21277,052 total
Footnotes (2)
  • [F1]The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]Includes 1 share acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 14, 2022.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4